dc.contributor.author |
Ker, James A.
|
|
dc.date.accessioned |
2011-04-05T10:07:41Z |
|
dc.date.available |
2011-04-05T10:07:41Z |
|
dc.date.issued |
2010-11 |
|
dc.description.abstract |
Statins are the most powerful cholesterol lowering drugs currently available. Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase, which leads to reduced cholesterol synthesis. In addition, low-density cholesterol receptors on the hepatocyte surface are upregulated, leading to increased clearance of cholesterol. The end result is a significant reduction in cholesterol levels, and a consequent significant reduction in mortality and cardiovascular events in the appropriate individual. |
en_US |
dc.identifier.citation |
Ker, JA 2010, 'The treatment of cholesterol : issues, effects and targets', South African Family Practice, vol. 52, no. 6, pp. 523-524. [http;//www.safpj.co.za] |
en_US |
dc.identifier.issn |
1726-426X (online) |
|
dc.identifier.issn |
1026-9177 (print) |
|
dc.identifier.uri |
http://hdl.handle.net/2263/16212 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
South African Academy of Family Practice/Primary Care |
en_US |
dc.rights |
© SAAFP |
en_US |
dc.subject |
Cholesterol |
en_US |
dc.subject |
Hypercholesterolemia |
en_US |
dc.subject |
Treatment |
en_US |
dc.subject |
Drug therapy |
en_US |
dc.subject |
Statins |
en_US |
dc.subject |
Effectivity |
en_US |
dc.subject |
LDL cholesterol |
en_US |
dc.subject |
Target |
en_US |
dc.subject |
Risk |
en_US |
dc.subject |
Prevention |
en_US |
dc.subject |
Elderly |
en_US |
dc.subject |
Time factors |
en_US |
dc.subject |
Atherosclerosis |
en_US |
dc.subject |
Safety |
en_US |
dc.subject.lcsh |
Cholesterol -- Treatment |
|
dc.title |
The treatment of cholesterol : issues, effects and targets |
en_US |
dc.type |
Article |
en_US |